US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 2.290
  • +0.050+2.23%
Close Dec 20 16:00 ET
  • 2.330
  • +0.040+1.75%
Post 20:01 ET
609.42MMarket Cap-1.88P/E (TTM)

Autolus Therapeutics Key Stats

Autolus Therapeutics Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
155.00K
0
-155.00K
Miss Est.
-61.82%
-100.00%
-100.00%
EPS
-0.22
-0.31
-0.09
Miss Est.
+16.66%
-19.23%
-43.12%
Strong Buy

Nov 30, 2024

Autolus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.517M--
--2024/Q4-- / 2.979M--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.517M--
--2024/Q4-- / 2.979M--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--

Unlock Free Earnings Estimates

Autolus Therapeutics Earnings Reports

Read more

Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data